Skip to main content
Fig. 3 | Inflammation and Regeneration

Fig. 3

From: Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis

Fig. 3

Forest plot: a meta-analysis of the duration of SARS-CoV-2 RNA positivity in the respiratory tract samples. The duration of SARS-CoV-2 RNA positivity from the onset of COVID-19 in the upper respiratory tract samples (a) and the sputum (b) was calculated using the random effects model. The difference in the duration of SARS-CoV-2 RNA positivity between the sputum and the upper respiratory samples was calculated using the random effects model (c). Experimental meant the sputum and control meant the upper respiratory tract samples. MRAW, the raw data of mean; 95%-CI, 95% confidence interval; SD, standard deviation; MD, mean difference

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us